Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

  • Candela Wins FDA Clearance for Psoriasis Device
Jan 2001
WAYLAND, Mass., Jan. 30 -- Candela Corp. has received clearance from the US Food and Drug Administration to market a laser for the treatment of psoriasis. The company said it is conducting on-going clinical trials and expects to market the device this coming summer.
Following acne, psoriasis is the second most common skin disorder in the United States, said Gerard E. Puorro, Candela's president and CEO. The market is underserved by current treatments. We are excited to be able to play a role in such a market.

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x We deliver – right to your inbox. Subscribe FREE to our newsletters.